NCT01597908 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 352
- group Id
- BG001
- value
- 352
- group Id
- BG002
- value
- 704
- units
- Participants
- groups
- description
- Dabrafenib 150 milligrams (mg) orally twice daily (BID) and Trametinib 2 mg orally once daily until disease progression, death, unacceptable toxicity, or withdrawal of consent.
- id
- BG000
- title
- Dabrafenib Plus Trametinib
- description
- Vemurafenib 960 mg orally BID until disease progression, death, unacceptable toxicity, or withdrawal of consent.
- id
- BG001
- title
- Vemurafenib
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 13.83
- value
- 54.1
- group Id
- BG001
- spread
- 14.06
- value
- 54.3
- group Id
- BG002
- spread
- 13.94
- value
- 54.2
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 144
- group Id
- BG001
- value
- 172
- group Id
- BG002
- value
- 316
- title
- Female
- measurements
- group Id
- BG000
- value
- 208
- group Id
- BG001
- value
- 180
- group Id
- BG002
- value
- 388
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 16
- title
- Asian - East Asian Heritage
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 6
- title
- White - Arabic/North African Heritage
- categories
- measurements
- group Id
- BG000
- value
- 339
- group Id
- BG001
- value
- 339
- group Id
- BG002
- value
- 678
- title
- White - White/Caucasian/European Heritage
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- White - Mixed Race
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Mixed Race
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- African American/African Heritage
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- American Indian or Alaskan Native
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 352
- group Id
- BG001
- value
- 352
- group Id
- BG002
- value
- 704
- units
- Participants
- groups
- description
- Dabrafenib 150 milligrams (mg) orally twice daily (BID) and Trametinib 2 mg orally once daily until disease progression, death, unacceptable toxicity, or withdrawal of consent.
- id
- BG000
- title
- Dabrafenib Plus Trametinib
- description
- Vemurafenib 960 mg orally BID until disease progression, death, unacceptable toxicity, or withdrawal of consent.
- id
- BG001
- title
- Vemurafenib
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 13.83
- value
- 54.1
- group Id
- BG001
- spread
- 14.06
- value
- 54.3
- group Id
- BG002
- spread
- 13.94
- value
- 54.2
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 144
- group Id
- BG001
- value
- 172
- group Id
- BG002
- value
- 316
- title
- Female
- measurements
- group Id
- BG000
- value
- 208
- group Id
- BG001
- value
- 180
- group Id
- BG002
- value
- 388
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 16
- title
- Asian - East Asian Heritage
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 6
- title
- White - Arabic/North African Heritage
- categories
- measurements
- group Id
- BG000
- value
- 339
- group Id
- BG001
- value
- 339
- group Id
- BG002
- value
- 678
- title
- White - White/Caucasian/European Heritage
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- White - Mixed Race
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Mixed Race
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- African American/African Heritage
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- American Indian or Alaskan Native
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle